Resurrect Bio Secures $10.3M in Series A Funding Round

UK-based Resurrect Bio has closed its Series A funding round at $10.3 million, following an initial close of $8.1 million. The investment, led by Corteva, aims to enhance disease resistance in crops and expand partnerships with seed companies and breeders.

Original excerpt: Resurrect Bio has announced the final close of its Series A round at $10.3 million…

Source: AgFunderNews